Innovative Neurotechnology Nia Therapeutics specializes in developing personalized neurostimulation therapies using AI, positioning it as a cutting-edge provider for medical facilities and clinics seeking advanced solutions for memory loss treatment.

Growing Market Focus With a primary focus on memory loss from traumatic brain injuries and plans to expand into mild cognitive impairment and Alzheimer's markets, there is significant potential for partnerships and product adoption within these sizable healthcare sectors.

Strategic Partnerships Recent collaborations with community and health organizations, such as the National Hispanic and Latino ATTC, highlight opportunities for outreach and commercialization within diverse patient populations and underserved communities.

Funding and Validation With $10 million raised and validated technology supported by clinical publications and animal model success, Nia presents an attractive investment and sales opportunity to entities interested in innovative neurotherapies.

Technological Edge Utilizing advanced design and coding tools (SOLIDWORKS, Fusion 360, C++, Python), Nia demonstrates a strong technical foundation, appealing to healthcare providers seeking reliable, technologically sophisticated therapeutic devices.